All Type of News
Announcement to re-assess economic effectiveness of medicines provokes protest
The government’s announcement to consider some pacts of the planned re-assessment of insurance-covered medicines over their economic effectiveness has provoked criticism from the labor unions of the National Health In...
Stillen’s sales in December top 6.8 billion won
Dong-A Pharma’s Stillen, Korea’s homegrown anti-ulcerant medicine, recorded 6.8 billion won in sales last December, a 31 percent jump from 2007, leading the domestic market, according to Ubist.
The market’s second ...
Peluvi fares well in analgesic/anti-inflammatory market
Daewon Pharm is enjoying brisk sales of its new nonsteroidal anti-inflammatory drug (NSAID), Peluvi (felubiprofen).
Sales of Daewon’s felubiprofen reached over 2.0 billion won since its release in October 2008, mak...
One Wyeth, seeking dream and hope
Wyeth Korea held its vision workshop at Hotel Lotte on January 22, with a theme titled “One Wyeth, seeking dream and hope”.
All employees participated in the workshop for more harmonious relations between labor-man...
KFDA okayed 399 clinical trials in 2008
The Korea Food and Drug Administration approved a total of 399 clinical trials last year, up 177 cases compared with 282 clinical trials in 2007.
According to the KFDA, the number of multinational clinical trials c...
Government to push up with re-assessment plan over 3,000 drugs
The government has reaffirmed that it will re-evaluate the economic effectiveness of 3,000 medicines listed in national health insurance this year without any modification, rejecting the speculation that the re-assess...
FTC urged to approve new regulatory guidelines
The Korea Pharmaceutical Manufacturers Association has called for the Fair Trade Commission to approve its revised version of regulatory guidelines.
The revised guidelines include regulations against undue rebates ...
Janssen Korea targets 210 billion won sales
Janssen Korea has set a goal of 210 billion won in sales this year, with its ambitious plan to launch four new drugs, such as Intelence, Jurnista, Invega and Yondelis.
- Intelence (etravirine) is a drug used for th...
Global management, R&D to drive up Daewoong
If global expansion topped Daewoong Pharm's growth strategy this year, the company’s fresh aim is to strengthen its position overseas and widen research and development in the life sciences industry.
Daewoong esta...
Doctors, pharmacists clash over prescription rights
Disputes are arising between doctors and pharmacists over who gets the right to prescribe medicines to patients.
While the pharmacists claim that the doctors should prescribe the active ingredients of a drug and th...
